Innovative Drug Sector Rises as Hansen Pharma Logs Fifth Consecutive Limit-Up

The innovative drug sector continued its upward momentum during trading on August 25, 2026, with multiple stocks trading actively. Hansen Pharmaceutical achieved its fifth consecutive daily limit-up, while Tellgen, Yuhuan Pharmaceutical, Huasen Pharmaceutical, Hainan Haiyao, and Xidian Pharmaceutical all hit the daily limit-up. Medicilon, Wanbang Pharmaceutical, and Jiankai Technology followed with gains.